The addition of EVs from LAMA84 CML cells to the human vascular endothelial cells (HUVEC) cell line increases survival and endothelial cell motility by promoting the expression of both ICAM-1 and VCAM-1 cell adhesion molecules and IL-8. Here, CXCL8 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.